Medical Science Liaison

Location: Montreal

Arrowhead Pharmaceuticals, Inc. (Nasdaq ARWR) is a commercial stage biopharmaceutical company that develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein.

Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.

Arrowhead is focused on developing innovative drugs for diseases with a genetic basis, typically characterized by the overproduction of one or more proteins that are involved with disease. The depth and versatility of our RNAi technologies enables us to potentially address conditions in virtually any therapeutic area and pursue disease targets that are not otherwise addressable by small molecules and biologics.

Arrowhead is leading the field in bringing the promise of RNAi to address diseases outside of the liver, and our clinical pipeline includes disease targets in the liver and lung with a promising pipeline of preclinical candidates.

Arrowhead’s corporate headquarters is in Pasadena, CA with research and development teams in Madison, WI & San Diego, CA, and a state of the art manufacturing facility in Verona, WI. Our employees are nimble, science-driven innovators who are collaborating to bring new therapies to patients in need.

The Position
Arrowhead is seeking an experienced Cardiometabolic Medical Science Liaison (MSL) to join the Medical Affairs (MA) team in a dynamic, collaborative environment. This is a field-based position, and the successful candidate must reside within one of the covered territories.

MSLs develop professional relationships with healthcare professionals through scientific engagement to support clinical-stage and launch molecules, engaging healthcare professionals through scientific exchange and providing clinical and scientific support.

We are seeking MSLs based from Montreal.

Responsibilities

Engage cardiologists, endocrinologists, and other healthcare professionals and stakeholders to educate on clinical and scientific evidence, advancing the treatment landscape in alignment with strategic imperatives.

Educate on RNAi technology, hypertriglyceridemia, familial chylomicronemia syndrome, and hypercholesterolemia.

Synthesize and communicate clinical and scientific insights to internal stakeholders.

Attend and present at scientific congresses and meetings to stay current with scientific developments and trends in the cardiometabolic therapeutic area.

Respond to unsolicited inquiries consistent with MSL compliance standards.

Support company-sponsored clinical trials through investigator site engagement.

Support speaker training as requested, ensuring speakers remain current with evolving disease and product data.

Support national, regional, and local scientific congresses, including Opinion Leader (OL) engagement, session coverage, booth support, and company debriefs.

Monitor and analyze scientific publications, clinical trials, and the competitive landscape in the cardiometabolic therapeutic area.

Maintain clinical and scientific expertise and general industry business acumen.

Advance the MSL value proposition, demonstrate tact and professionalism, and deliver results.

Act in accordance with company policies.

Develop territory-specific OL and account plans, including OL profiles, planning, and follow-up.

Communicate clinical and scientific information accurately and clearly.

Document MSL quantitative and qualitative accomplishments.

Provide…